company background image
ABLD logo

ABL Diagnostics Société anonyme ENXTPA:ABLD Stock Report

Last Price

€3.18

Market Cap

€51.2m

7D

0%

1Y

n/a

Updated

27 Mar, 2024

Data

Company Financials

ABL Diagnostics Société anonyme

ENXTPA:ABLD Stock Report

Market Cap: €51.2m

ABLD Stock Overview

ABL Diagnostics Société anonyme provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and internationally.

ABLD fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance1/6
Financial Health4/6
Dividends0/6

ABL Diagnostics Société anonyme Competitors

Price History & Performance

Summary of all time highs, changes and price drops for ABL Diagnostics Société anonyme
Historical stock prices
Current Share Price€3.18
52 Week High€9.70
52 Week Low€3.18
Beta-0.16
1 Month Change-67.22%
3 Month Change-67.22%
1 Year Changen/a
3 Year Change27.20%
5 Year Change-20.00%
Change since IPO195.88%

Recent News & Updates

Recent updates

Shareholder Returns

ABLDFR Trade DistributorsFR Market
7D0%3.8%-0.4%
1Yn/a14.1%10.6%

Return vs Industry: Insufficient data to determine how ABLD performed against the French Trade Distributors industry.

Return vs Market: Insufficient data to determine how ABLD performed against the French Market.

Price Volatility

Is ABLD's price volatile compared to industry and market?
ABLD volatility
ABLD Average Weekly Movement18.9%
Trade Distributors Industry Average Movement3.5%
Market Average Movement4.3%
10% most volatile stocks in FR Market10.0%
10% least volatile stocks in FR Market2.2%

Stable Share Price: ABLD's share price has been volatile over the past 3 months.

Volatility Over Time: ABLD's weekly volatility has increased from 14% to 19% over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a21Ronan Boulmehttps://www.abldiagnostics.com

ABL Diagnostics Société anonyme provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and internationally. It offers genotyping through NGS and sanger sequencing for human immunodeficiency virus, SARS CoV-2, hepatitis-C virus, mycobacterium tuberculosis, and 16S RNA; ultragene assays for viral detection of SARS CoV-2, dengue, and Zika virus; microbiological specimen transport and collection kits, which include RNA and saliva preservation, wastewater collection, and surface collection kits, as well as inactivation and preservation solution; and instrument and consumables, such as DNA/RNA extraction system, real-time PCR system, liquid handling robot, NGS library preparation system, and sanger sequencing reagents. The company also provides digital solutions comprising analysis software, data hosting, lab automation, Nadis, and SeqHepB.

ABL Diagnostics Société anonyme Fundamentals Summary

How do ABL Diagnostics Société anonyme's earnings and revenue compare to its market cap?
ABLD fundamental statistics
Market cap€51.24m
Earnings (TTM)€1.20m
Revenue (TTM)€12.26m

42.6x

P/E Ratio

4.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ABLD income statement (TTM)
Revenue€12.26m
Cost of Revenue€8.90m
Gross Profit€3.36m
Other Expenses€2.16m
Earnings€1.20m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.075
Gross Margin27.43%
Net Profit Margin9.81%
Debt/Equity Ratio44.9%

How did ABLD perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.